What a useful human trial would need to measure Safety and side effects Blood levels and oral bioavailability How long the compound remains in the body Direct proof that NNMT is being inhibited Body weight, fat mass, and lean mass Glucose, insulin, liver, and lipid markers Changes after treatment stops Results compared with a placebo group Why human-equivalent dose math does not predict results Body-surface-area math can help researchers choose a starting range for future safety work
Mouse metabolism, mouse fat biology, and mouse dosing all differ from the human versions, and metabolic findings in rodents have a long history of not carrying over cleanly to people
Once the therapy begins, 5-Amino-1MQ enters the system and starts working at the cellular level
Procedure Start met uw aanvraag Neem contact met ons op en deel uw specifieke behoeften
Oracle - What is the safety and efficacy of BPC-157 for fracture healing?: Discusses preclinical evidence for fracture care and lack of human validation